1. 447 Extended Analysis for Cancer Treatment (EXACT): Interim analysis of a prospective precision medicine trial. (September 2015) Authors: Prager, G.; Unseld, M.; Waneck, F.; Raderer, M.; Krainer, M.; Fuereder, T.; Hejna, M.; Staber, P.; Scheithauer, W.; Schmidinger, M.; Thallinger, C.; Farkas, L.; Reinthaller, A.; Polterauer, S.; Wrba, F.; Muellauer, L.; Mader, R.; Zielinski, C.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐OX40L alone or in combination with anti‐CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen. Issue 2 (February 2016) Authors: Gattringer, M.; Baranyi, U.; Pilat, N.; Hock, K.; Klaus, C.; Ramsey, H. E.; Wrba, F.; Valenta, R.; Wekerle, T. Journal: Clinical & experimental allergy Issue: Volume 46:Issue 2(2016:Feb.) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years. Issue 2 (25th November 2016) Authors: Eigner, W.; Bashir, K.; Primas, C.; Kazemi‐Shirazi, L.; Wrba, F.; Trauner, M.; Vogelsang, H. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 2(2017) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MONDTI: Molecular characterisation platform for identifying actionable mutations in advanced or metastatic cancers. (December 2016) Authors: Kieler, M.; Warzecha, A.; Müllauer, L.; Waneck, F.; Mader, R.; Wrba, F.; Schmidinger, M.; Scheithauer, W.; Marosi, C.; Raderer, M.; Hejna, M.; Füreder, T.; Staber, P.; Preusser, M.; Jäger, U.; Reinthaller, A.; Berger, W.; Bartsch, R.; Zielinski, C.; Prager, G. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P16INK4a Immunohistochemistry for Detection of Human Papilloma Virus-Associated Penile Squamous Cell Carcinoma is Superior to in-Situ Hybridization. (July 2013) Authors: Aumayr, K.; Susani, M.; Horvat, R.; Wrba, F.; Mazal, P.; Klatte, T.; Koller, A.; Neudert, B.; Haitel, A. Journal: International journal of immunopathology and pharmacology Issue: Volume 26:Number 3(2013) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P28 HPV/p16 positivity is associated with improved survival in oropharyngeal cancer patients treated with postoperative radiotherapy. Issue 5 (May 2015) Authors: , .; Grah, A.; Oberndorfer, F.; Kadletz, L.; Altorjai, G.; Kornek, G.; Wrba, F.; Thurnher, D.; Selzer, E. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P28 HPV/p16 positivity is associated with improved survival in oropharyngeal cancer patients treated with postoperative radiotherapy. Issue 5 (May 2015) Authors: Heiduschka, G.; Grah, A.; Oberndorfer, F.; Kadletz, L.; Altorjai, G.; Kornek, G.; Wrba, F.; Thurnher, D.; Selzer, E. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P28 HPV/p16 positivity is associated with improved survival in oropharyngeal cancer patients treated with postoperative radiotherapy. Issue 5 (May 2015) Authors: Heiduschka, G.; Grah, A.; Oberndorfer, F.; Kadletz, L.; Altorjai, G.; Kornek, G.; Wrba, F.; Thurnher, D.; Selzer, E. Journal: Oral oncology Issue: Volume 51:Issue 5(2015:May) Page Start: e51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. (April 2016) Authors: Kosulin, K.; Geiger, E.; Vécsei, A.; Huber, W.-D.; Rauch, M.; Brenner, E.; Wrba, F.; Hammer, K.; Innerhofer, A.; Pötschger, U.; Lawitschka, A.; Matthes-Leodolter, S.; Fritsch, G.; Lion, T. Journal: Clinical microbiology and infection Issue: Volume 22:Number 4(2016) Page Start: 381.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prophylactic and therapeutic vaccination with carrier‐bound Bet v 1 peptides lacking allergen‐specific T cell epitopes reduces Bet v 1‐specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Issue 2 (22nd January 2014) Authors: Linhart, B.; Narayanan, M.; Focke‐Tejkl, M.; Wrba, F.; Vrtala, S.; Valenta, R. Journal: Clinical & experimental allergy Issue: Volume 44:Issue 2(2014:Feb.) Page Start: 278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗